Company profile

Orchidia Pharmaceutical Industries S.A.E.

Orchidia Pharmaceutical Industries S.A.E. is an Egypt-based pharmaceutical manufacturer specialising in ophthalmic products. Established in 1993, the company operates a 6,000 square metre manufacturing facility in Al-Obour City, Cairo, which is considered one of the largest ophthalmic-focused plants in the Middle East. The facility has a production capacity of 35 million units annually. Orchidia ranks second in the Egyptian ophthalmic market and has achieved the highest growth rate in this segment. Its portfolio comprises 35 ophthalmic drugs and three CE-marked medical devices, supported by a pipeline of 60 additional ophthalmic drugs in development. Beyond ophthalmology, the company also produces lens care solutions, cosmeceuticals, and supplements. Orchidia is certified for WHO-GMP implementation by the Egyptian Ministry of Health and other regulatory authorities in the Middle East and Africa, and holds ISO 9001, ISO 14001, and OHSAS certifications. The company maintains Quality Management Systems and Environmental Health and Safety frameworks that comply with international standards, supporting export activities to over 40 countries across Africa and the Middle East.

Sector

Healthcare / Pharmaceuticals

Markets

Egypt

Ownership

Private

Source: Partner Researchers.